Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 2
1989 1
1990 1
2001 1
2007 2
2008 4
2009 4
2010 5
2011 1
2012 3
2013 1
2014 2
2015 2
2016 1
2017 5
2018 3
2019 5
2020 4
2021 5
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Nordlinger B, et al. Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9. Lancet. 2008. PMID: 18358928 Free PMC article. Clinical Trial.
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators. Eng C, et al. Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16. Lancet Oncol. 2019. PMID: 31003911 Clinical Trial.
A double-blind randomized, multicenter, placebo-controlled study of itopride in functional dyspepsia postprandial distress syndrome.
Carbone F, Vandenberghe A, Holvoet L, Piessevaux H, Arts J, Caenepeel P, Staessen D, Vergauwe P, Maldague P, De Ronde T, Wuestenberghs F, Lamy V, Lefebvre V, Latour P, Vanuytsel T, Jones M, Tack J. Carbone F, et al. Among authors: vergauwe p. Neurogastroenterol Motil. 2022 Aug;34(8):e14337. doi: 10.1111/nmo.14337. Epub 2022 Mar 31. Neurogastroenterol Motil. 2022. PMID: 35357058 Free article. Clinical Trial.
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Vandeputte C, Bregni G, Gkolfakis P, Guiot T, Pretta A, Kehagias P, Senti C, Reina EA, Van Bogaert C, Deleporte A, Geboes K, Delaunoit T, Demolin G, Peeters M, D'Hondt L, Janssens J, Carrasco J, Holbrechts S, Goeminne JC, Vergauwe P, Van Laethem JL, Flamen P, Hendlisz A, Sclafani F. Vandeputte C, et al. Among authors: vergauwe p. Clin Colorectal Cancer. 2021 Dec;20(4):326-333. doi: 10.1016/j.clcc.2021.07.006. Epub 2021 Jul 24. Clin Colorectal Cancer. 2021. PMID: 34404621 Clinical Trial.
A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium.
Verbruggen L, Verheggen L, Vanhoutte G, Loly C, Lybaert W, Borbath I, Vergauwe P, Hendrickx K, Debeuckelaere C, de Haar-Holleman A, Van Laethem JL, Peeters M. Verbruggen L, et al. Among authors: vergauwe p. Ther Adv Med Oncol. 2023 Aug 18;15:17588359231181500. doi: 10.1177/17588359231181500. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37600936 Free PMC article.
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.
van Asseldonk DP, Sanderson J, de Boer NK, Sparrow MP, Lémann M, Ansari A, Almer SH, Florin TH, Gearry RB, Mulder CJ, Mantzaris G, van Bodegraven AA; Thiopurine Task Force Interest Group. van Asseldonk DP, et al. Dig Liver Dis. 2011 Apr;43(4):270-6. doi: 10.1016/j.dld.2010.09.001. Epub 2010 Oct 8. Dig Liver Dis. 2011. PMID: 20934926 Review.
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care.
Van den Houte K, Carbone F, Goelen N, Schol J, Masuy I, Arts J, Caenepeel P, Staessen D, Vergauwe P, Van Roey G, Latour P, Piessevaux H, Maldague P, Gerkens A, Wuestenberghs F, Vandenberghe A, Tack J. Van den Houte K, et al. Among authors: vergauwe p. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1620-1626. doi: 10.1016/j.cgh.2020.06.043. Epub 2020 Jul 6. Clin Gastroenterol Hepatol. 2021. PMID: 32645450 Free article.
48 results